Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 14/20 | 0.62 |
| ▸ | ABCB1 | P08183 | 8/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.50 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.50 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.50 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.50 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.50 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.49 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22360641 | 0.98 | ABCG2 (0.60) | ABCG2ABCB1TSHRABCC1CYP11B2 | |
| SCHEMBL20396079 | 0.98 | ABCG2 (0.60) | ABCG2ABCB1TSHRABCC1CYP11B2 | |
| SCHEMBL22106575 | 0.98 | ABCG2 (0.60) | ABCG2ABCB1TSHRABCC1CYP11B2 | |
| SCHEMBL23383850 | 0.98 | ABCG2 (0.60) | ABCG2ABCB1TSHRABCC1CYP11B2 | |
| SCHEMBL19939304 | 0.98 | ABCG2 (0.60) | ABCG2ABCB1TSHRABCC1CYP11B2 | |
| SCHEMBL23384091 | 0.98 | ABCG2 (0.60) | ABCG2ABCB1TSHRABCC1CYP11B2 | |
| SCHEMBL22883053 | 0.98 | ABCG2 (0.60) | ABCG2ABCB1TSHRABCC1CYP11B2 | |
| SCHEMBL23383904 | 0.98 | ABCG2 (0.60) | ABCG2ABCB1TSHRABCC1CYP11B2 | |
| SCHEMBL19939303 | 0.98 | ABCG2 (0.60) | ABCG2ABCB1TSHRABCC1CYP11B2 | |
| SCHEMBL22414164 | 0.92 | ABCG2 (0.59) | ABCG2ABCB1TSHRABCC1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250359476-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX INC (JP) | 2025-11-20 | — | — | US | disclosed |
| US-12369492-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2025-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250359476-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | ABCG2 75/4885ABCB1 560/4885TSHR 4805/4885 |
| US-12369492-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, SLCO1B3, NDUFV3 | ABCG2 75/4885ABCB1 560/4885TSHR 4805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.